762 related articles for article (PubMed ID: 19286222)
1. Sex cord stromal testicular tumors: a clinical series--uniformly stage I disease.
Featherstone JM; Fernando HS; Theaker JM; Simmonds PD; Hayes MC; Mead GM
J Urol; 2009 May; 181(5):2090-6; discussion 2096. PubMed ID: 19286222
[TBL] [Abstract][Full Text] [Related]
2. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
Mosharafa AA; Foster RS; Bihrle R; Koch MO; Ulbright TM; Einhorn LH; Donohue JP
Cancer; 2003 Aug; 98(4):753-7. PubMed ID: 12910519
[TBL] [Abstract][Full Text] [Related]
3. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
4. Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors.
Calaway AC; Tachibana I; Masterson TA; Foster RS; Einhorn LH; Cary C
Urology; 2019 May; 127():74-79. PubMed ID: 30807775
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
6. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
7. Current treatment of testicular sex cord-stromal tumors: critical review.
Acar C; Gurocak S; Sozen S
Urology; 2009 Jun; 73(6):1165-71. PubMed ID: 19362328
[TBL] [Abstract][Full Text] [Related]
8. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
[TBL] [Abstract][Full Text] [Related]
10. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
Cooper DE; L'esperance JO; Christman MS; Auge BK
J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.
Nicolai N; Necchi A; Raggi D; Biasoni D; Catanzaro M; Piva L; Stagni S; Maffezzini M; Torelli T; Faré E; Giannatempo P; Pizzocaro G; Colecchia M; Salvioni R
Urology; 2015 Feb; 85(2):402-6. PubMed ID: 25623702
[TBL] [Abstract][Full Text] [Related]
12. Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up.
Hölscher G; Anthuber C; Bastert G; Burges A; Mayr D; Oberlechner E; Schubert-Fritschle G; Sinz S; Sommer H; Schmalfeldt B; Engel J;
Acta Obstet Gynecol Scand; 2009; 88(4):440-8. PubMed ID: 19191075
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
[TBL] [Abstract][Full Text] [Related]
14. [Long-term outcome of testicular seminoma in 294 patients].
Song Y; Yang L; Ma JH; Liu XF; Wang JW
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):626-9. PubMed ID: 19102945
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
[TBL] [Abstract][Full Text] [Related]
16. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.
Spiess PE; Brown GA; Liu P; Tannir NM; Tu SM; Evans JG; Czerniak B; Kamat AM; Pisters LL
Cancer; 2006 Oct; 107(7):1483-90. PubMed ID: 16944541
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
[TBL] [Abstract][Full Text] [Related]
19. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
20. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.
Sánchez-Ortiz R; Huang SF; Tamboli P; Prieto VG; Hester G; Pettaway CA
J Urol; 2005 Jun; 173(6):1958-65. PubMed ID: 15879790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
